Featured authors from NAE’s The Bridge introduce two initiatives shaping the future of advanced biomanufacturing. The NIST Biomanufacturing Program provides high quality reference materials to support advances in development, characterization and manufacturing of protein drugs. The NIIMBL Open-Access Viral Vector Platform accelerates AAV-based gene therapy for rare diseases, offering scalable processes and a collaborative framework that broadens participation and streamlines innovation for life-saving medicines.